IRIS Accounts Production v24.3.0.553 12722024 Board of Directors 1.4.23 31.3.24 31.3.24 false true false false false false 8250 8250 iso4217:GBPiso4217:USDiso4217:EURxbrli:sharesxbrli:pureutr:tonnesutr:kWh127220242023-03-31127220242024-03-31127220242023-04-012024-03-31127220242022-03-31127220242022-04-012023-03-31127220242023-03-3112722024ns15:EnglandWales2023-04-012024-03-3112722024ns14:PoundSterling2023-04-012024-03-3112722024ns10:Director12023-04-012024-03-3112722024ns10:PrivateLimitedCompanyLtd2023-04-012024-03-3112722024ns10:Micro-entities2023-04-012024-03-3112722024ns10:AuditExempt-NoAccountantsReport2023-04-012024-03-3112722024ns10:FullAccounts2023-04-012024-03-311272202412023-04-012024-03-3112722024ns10:Director2422023-04-012024-03-3112722024ns10:Director2422024-03-3112722024ns10:Director22023-04-012024-03-3112722024ns10:RegisteredOffice2023-04-012024-03-3112722024ns5:CurrentFinancialInstruments2024-03-3112722024ns5:CurrentFinancialInstruments2023-03-3112722024ns5:Non-currentFinancialInstruments2024-03-3112722024ns5:Non-currentFinancialInstruments2023-03-31127220241ns10:Director12023-03-31127220241ns10:Director12022-03-31127220241ns10:Director12023-04-012024-03-31127220241ns10:Director12022-04-012023-03-31127220241ns10:Director12024-03-31127220241ns10:Director12023-03-31
REGISTERED NUMBER: 12722024 (England and Wales)

















UNAUDITED FINANCIAL STATEMENTS FOR THE YEAR ENDED 31 MARCH 2024

FOR

EDEN PHARMACY & HEALTHCARE LIMITED

EDEN PHARMACY & HEALTHCARE LIMITED (BY SHARES) (REGISTERED NUMBER: 12722024






CONTENTS OF THE FINANCIAL STATEMENTS
FOR THE YEAR ENDED 31 MARCH 2024




Page

Company Information 1

Balance Sheet 2


EDEN PHARMACY & HEALTHCARE LIMITED (BY SHARES)

COMPANY INFORMATION
FOR THE YEAR ENDED 31 MARCH 2024







DIRECTORS: Mrs. D F Hepple
Mr. D Hepple



REGISTERED OFFICE: 3 Leasingthorne Way
Newcastle Upon Tyne
NE13 9BQ



REGISTERED NUMBER: 12722024 (England and Wales)



ACCOUNTANTS: Read, Milburn & Co
71 Howard Street
North Shields
Tyne and Wear
NE30 1AF



BANKERS: Starling Bank Limited
2 Finsbury Avenue
London
EC2M 2PP

EDEN PHARMACY & HEALTHCARE LIMITED (BY SHARES) (REGISTERED NUMBER: 12722024

BALANCE SHEET
31 MARCH 2024

2024 2023
£    £    £    £   
FIXED ASSETS 218,407 251,594

CURRENT ASSETS 86,819 106,708

CREDITORS
Amounts falling due within one year (154,488 ) (152,019 )
NET CURRENT LIABILITIES (67,669 ) (45,311 )
TOTAL ASSETS LESS CURRENT
LIABILITIES

150,738

206,283

CREDITORS
Amounts falling due after more than one
year

198,983

208,565
NET LIABILITIES (48,245 ) (2,282 )

CAPITAL AND RESERVES (48,245 ) (2,282 )

NOTES TO THE FINANCIAL STATEMENTS

1. AVERAGE NUMBER OF EMPLOYEES

The average number of employees during the year was 9 (2023 - 5 ) .

2. DIRECTORS' ADVANCES, CREDITS AND GUARANTEES

The following advances and credits to directors subsisted during the years ended 31 March 2024 and 31 March 2023:

2024 2023
£    £   
Mrs. D F Hepple and Mr. D Hepple
Balance outstanding at start of year - -
Amounts advanced 8,250 -
Amounts repaid - -
Amounts written off - -
Amounts waived - -
Balance outstanding at end of year 8,250 -

EDEN PHARMACY & HEALTHCARE LIMITED (BY SHARES) (REGISTERED NUMBER: 12722024

BALANCE SHEET - continued
31 MARCH 2024

NOTES TO THE FINANCIAL STATEMENTS

3. OTHER FINANCIAL COMMITMENTS

At the Balance Sheet date the company was committed to the following minimum payments under non-cancellable operating leases::

Amounts due within one year - £17,640 (2023 - £17,640)
Amounts due between one and five years - £19,030 (2023 - £36,670)



The company is entitled to exemption from audit under Section 477 of the Companies Act 2006 for the year ended 31 March 2024.

The members have not required the company to obtain an audit of its financial statements for the year ended 31 March 2024 in accordance with Section 476 of the Companies Act 2006.

The directors acknowledge their responsibilities for:
(a)ensuring that the company keeps accounting records which comply with Sections 386 and 387 of the Companies Act 2006 and
(b)preparing financial statements which give a true and fair view of the state of affairs of the company as at the end of each financial year and of its profit or loss for each financial year in accordance with the requirements of Sections 394 and 395 and which otherwise comply with the requirements of the Companies Act 2006 relating to financial statements, so far as applicable to the company.

The financial statements have been prepared in accordance with the micro-entity provisions and delivered in accordance with the provisions applicable to companies subject to the small companies regime.

The financial statements were approved by the Board of Directors and authorised for issue on 7 October 2024 and were signed on its behalf by:





Mrs. D F Hepple - Director